| Market Cap | $49.5M | |
| Enterprise Value | — | |
| Revenue | $234,000 | +7.1% |
| Gross Profit | -$640,000 | — |
| EBITDA | -$22.8M | — |
| Net Income | -$23.1M | — |
| Diluted EPS | -$1.23 | — |
| Free Cash Flow | -$20.7M | — |
| DPS (FY2025) | $0.08derived |
| Trailing yield | 12.16% |
| Payout ratio | — |
| Growth streak | 0 yrs |
| 5y DPS growth | — |
| Fiscal year | DPS | YoY | Basis |
|---|---|---|---|
| FY20252025-12-31 | $0.08 | −39.9% | derived (paid ÷ diluted shares) |
| FY20242024-12-31 | $0.13 | — | derived (paid ÷ diluted shares) |
| Ratio | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Trend · 6y | vs own | vs sector |
|---|---|---|---|---|---|---|---|---|---|
| ▾Margins | |||||||||
| Gross Margin | — | — | −110.13% | −149.68% | −229.78% | −262.66% | 13% | 1% | |
| Operating Margin | — | — | −3673.42% | −5809.81% | −8558.22% | −9240.66% | 13% | 5% | |
| EBITDA Margin | — | — | −3641.77% | −5767.72% | −8481.33% | −9115.35% | 13% | 5% | |
| NOPAT Margin | — | — | −3407.38% | — | — | — | — | — | — |
| Net Margin | — | — | −6718.57% | −9468.99% | −9242.22% | −9857.26% | 13% | 5% | |
| FCF Margin | — | — | −3807.17% | −5456.96% | −8412.89% | −7626.56% | 38% | 5% | |
| OCF Margin | — | — | −3715.19% | −5408.54% | −7977.33% | −7552.28% | 38% | 5% | |
| Gross Profitability | — | — | −10.21% | −5.72% | −4.48% | −7.40% | 38% | 1% | |
| Capex Intensity | — | — | 91.98% | 48.42% | 435.56% | 74.27% | 38% | 94% | |
| ▸Returns on Capital · 2 ratios | |||||||||
| ▸DuPont factors (ROE drivers) · 3 ratios | |||||||||
| ▸Earnings quality · 2 ratios | |||||||||
| ▸Liquidity & coverage · 6 ratios | |||||||||
| ▸Leverage · 2 ratios | |||||||||
| ▸Working capital · 8 ratios | |||||||||
| ▸Per share · 6 ratios | |||||||||
| ▸Other · 1 ratios | |||||||||
| Line | 2021↗ | 2022↗ | 2023↗ | 2024↗ | 2025↗ |
|---|---|---|---|---|---|
| Revenue | — | $237,000 | $316,000 | $225,000 | $241,000 |
| YoY % | +33.3% | -28.8% | +7.1% | ||
| Cost of Revenue | — | $498,000 | $789,000 | $742,000 | $874,000 |
| YoY % | +58.4% | -6.0% | +17.8% | ||
| R&D Expense | — | $5.0M | $9.0M | $10.2M | $12.5M |
| YoY % | +80.0% | +13.7% | +22.7% | ||
| Selling & Marketing Expense | — | $885,000 | $1.7M | $1.7M | $1.2M |
| YoY % | +88.2% | +4.1% | -29.6% | ||
| SG&A Expense | — | — | $7.3M | $6.8M | $7.9M |
| YoY % | -6.0% | +16.2% | |||
| Total Operating Expenses | — | $8.9M | $18.7M | $19.5M | $22.5M |
| YoY % | +108.8% | +4.3% | +15.6% | ||
| Operating Income | -$5.2M | -$8.7M | -$18.4M | -$19.3M | -$22.3M |
| Interest Expense | — | — | — | $816,000 | $1.6M |
| YoY % | +94.9% | ||||
| Interest & Investment Income | $37,665 | $6.1M | — | — | — |
| YoY % | +16161.9% | ||||
| Other Non-Operating Income | — | -$127,000 | $54,000 | -$26,000 | -$23,000 |
| Impairment of Real Estate | — | — | — | $0 | — |
| Pretax Income | -$251,633 | $20.7M | — | -$20.8M | -$23.8M |
| Income Tax | — | $1.5M | — | — | — |
| Net Income (incl. NCI) | -$251,633 | $19.2M | — | — | — |
| Net Income | -$251,633 | -$15.9M | -$29.9M | -$20.8M | -$23.8M |
| Net Income to Common | — | -$15.9M | -$31.3M | -$28.0M | -$28.7M |
| EPS (Basic) | — | -$1.57 | -$2.54 | -$1.49 | -$1.23 |
| EPS (Diluted) | — | -$1.57 | -$2.54 | -$1.49 | -$1.23 |
| Weighted Avg Shares (Basic) | — | 10.1M | 12.3M | 18.8M | 23.3M |
| YoY % | +21.5% | +52.8% | +23.8% | ||
| Weighted Avg Shares (Diluted) | — | 10.1M | 12.3M | 18.8M | 23.3M |
| YoY % | +21.5% | +52.8% | +23.8% |
The sector classification is SIC-derived, not official GICS. Statement lines are XBRL facts as filed with the company's home regulator (SEC EDGAR for US filers; ESEF/EDINET and other national regulators for foreign filers); ratios and other derived figures are computed from them. A blank cell means the tag was absent — never imputed.
